Published June 13, 2013 | Version v1
Patent Open

PROGNOSIS AND THERAPY PREDICTIVE MARKERS AND METHODS OF USE

Description

Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.

Files

US20130150258.pdf

Files (1.3 MB)

Name Size Download all
md5:12da024e0d574446b64d2dc35a8ce945
1.3 MB Preview Download

Additional details

Identifiers

Patent number
US 201313734527 A
Patent application number
US 2013/0150258 A1
Other
oai:uchicago.tind.io:9457

Dates

Patent filed
2013-01-04

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Microbiology, Radiation and Cellular Oncology, Pathology